Spatial sequestration of dynamic nucleic acid circuits

US9796748B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9796748-B2
Application numberUS-201214114961-A
CountryUS
Kind codeB2
Filing dateMay 2, 2012
Priority dateMay 2, 2011
Publication dateOct 24, 2017
Grant dateOct 24, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides systems and methods for spatial sequestration of elements in nucleic acid circuits.

First claim

Opening claim text (preview).

What is claimed is: 1. A synthetic system comprising (a) a first three-dimensional nucleic acid nanostructure shaped in the form of a container comprising walls, an interior surface and an exterior surface, (b) a first tethered nucleic acid attached to the interior surface of the first three-dimensional nucleic acid nanostructure and partially hybridized to a first output signal nucleic acid, wherein the first tethered nucleic acid contains a toehold domain that is not complementary to the first output signal nucleic acid, (c) a second three-dimensional nucleic acid nanostructure shaped in the form of a container comprising walls, an interior surface and an exterior surface, and (d) a second tethered nucleic acid attached to the interior surface of the second three-dimensional nucleic acid nanostructure and partially hybridized to a second output signal nucleic acid, wherein the second tethered nucleic acid contains a toehold domain that is not complementary to the second output signal nucleic acid, and wherein the toehold domain of the second tethered nucleic acid is complementary to a domain of the first output signal nucleic acid. 2. The system of claim 1 , wherein the first and second tethered nucleic acids are not integral to the first and second nucleic acid nanostructures. 3. The system of claim 1 , wherein the first and second nucleic acid nanostructures are independently selected from the group consisting of closed nucleic acid nanostructures and open nucleic acid nanostructures. 4. The system of claim 3 , wherein the open nucleic acid nanostructures comprise two open ends. 5. The system of claim 3 , wherein the closed nucleic acid nanostructures comprise a nucleic acid lock. 6. The system of claim 1 , further comprising one or more upstream and/or downstream nucleic acid nanostructures. 7. The system of claim 6 , wherein the one or more of the upstream and/or downstream nucleic acid nanostructures comprise tethered nucleic acid. 8. A method comprising contacting a first input signal nucleic acid with the system of claim 1 in an amount effective to release the second output signal nucleic acid from the second nucleic acid nanostructure. 9. The system of claim 6 , wherein the one or more of the upstream and/or downstream nucleic acid nanostructures comprise free flowing nucleic acids. 10. The system of claim 9 , wherein the free flowing nucleic acids are output signal nucleic acids. 11. The system of claim 1 , wherein the first nucleic acid nanostructures and/or the second nucleic acid nanostructure comprises an agent. 12. The system of claim 11 , wherein the agent is or comprises a therapeutic agent. 13. The system of claim 11 , wherein the agent is or comprises a detectable marker. 14. The system of claim 1 , wherein the first nucleic acid nanostructures and/or the second nucleic acid nanostructure comprises a plurality of tethered nucleic acids. 15. The system of claim 1 , wherein the first nucleic acid nanostructures and/or the second nucleic acid nanostructure comprises a plurality of free flowing nucleic acids. 16. The system of claim 1 , wherein the length of the toehold domain of the first tethered nucleic acid is 4-12 nucleotides. 17. The system of claim 1 , wherein the length of the toehold domain of the second tethered nucleic acid is 4-12 nucleotides. 18. The system of claim 1 , wherein the first nucleic acid nanostructure is a deoxyribonucleic acid (DNA) nanostructure. 19. The system of claim 1 , wherein the second nucleic acid nanostructure is a DNA nanostructure.

Assignees

Inventors

Classifications

  • Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors · CPC title

  • Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title

  • C07H21/04Primary

    with deoxyribosyl as saccharide radical · CPC title

  • Composed of biological material · CPC title

  • using radioactive material · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9796748B2 cover?
The invention provides systems and methods for spatial sequestration of elements in nucleic acid circuits.
Who is the assignee on this patent?
Schaus Thomas E, Zhang David Yu, Sun Wei, and 2 more
What technology area does this patent fall under?
Primary CPC classification C07H21/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).